GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Deltex Medical Group PLC (LSE:DEMG) » Definitions » EV-to-EBITDA

Deltex Medical Group (LSE:DEMG) EV-to-EBITDA : -2.58 (As of Jan. 19, 2025)


View and export this data going back to 2001. Start your Free Trial

What is Deltex Medical Group EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Deltex Medical Group's enterprise value is £2.27 Mil. Deltex Medical Group's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 was £-0.88 Mil. Therefore, Deltex Medical Group's EV-to-EBITDA for today is -2.58.

The historical rank and industry rank for Deltex Medical Group's EV-to-EBITDA or its related term are showing as below:

LSE:DEMG' s EV-to-EBITDA Range Over the Past 10 Years
Min: -25.15   Med: -3.97   Max: 54.89
Current: -2.58

During the past 13 years, the highest EV-to-EBITDA of Deltex Medical Group was 54.89. The lowest was -25.15. And the median was -3.97.

LSE:DEMG's EV-to-EBITDA is ranked worse than
100% of 479 companies
in the Medical Devices & Instruments industry
Industry Median: 16.03 vs LSE:DEMG: -2.58

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2025-01-19), Deltex Medical Group's stock price is £0.0004. Deltex Medical Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was £-0.001. Therefore, Deltex Medical Group's PE Ratio (TTM) for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Deltex Medical Group EV-to-EBITDA Historical Data

The historical data trend for Deltex Medical Group's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Deltex Medical Group EV-to-EBITDA Chart

Deltex Medical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 40.37 -17.85 -14.18 -10.54 -4.08

Deltex Medical Group Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -10.54 - -4.08 -

Competitive Comparison of Deltex Medical Group's EV-to-EBITDA

For the Medical Devices subindustry, Deltex Medical Group's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Deltex Medical Group's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Deltex Medical Group's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Deltex Medical Group's EV-to-EBITDA falls into.



Deltex Medical Group EV-to-EBITDA Calculation

Deltex Medical Group's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=2.268/-0.879
=-2.58

Deltex Medical Group's current Enterprise Value is £2.27 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Deltex Medical Group's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 was £-0.88 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Deltex Medical Group  (LSE:DEMG) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Deltex Medical Group's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.0004/-0.001
=At Loss

Deltex Medical Group's share price for today is £0.0004.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Deltex Medical Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was £-0.001.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Deltex Medical Group EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Deltex Medical Group's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Deltex Medical Group Business Description

Traded in Other Exchanges
N/A
Address
Terminus Road, Chichester, West Sussex, GBR, PO19 8TX
Deltex Medical Group PLC is a British manufacturer of Fluid Management devices, which include the ODM and now ODM+ haemodynamic monitoring systems. The company has developed the gold standard for haemodynamic monitoring with oesophageal Doppler technology, which is marketed as TrueVue Doppler and often generically referred to by clinicians as ODM. The company's initial and principal technology is Doppler-based ultrasound oesophageal haemodynamic monitoring.

Deltex Medical Group Headlines

No Headlines